The farce surrounding the development of a US over-the-counter (OTC) category for the sales of low-cost hearing aids continues.
For some years, hearing aid manufacturers of all sizes and shapes have been waiting with anticipation for the US Food and Drug authority (FDA) to provide the guidelines which will define the contours of how OTC sales of hearing aids will operate in the future.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.